Similarly, chemokines Ccl2 (MCP-1) and Cxcl2 (MIP-2) mRNA expression was dramatically higher in the NASH group, showing 72.11-fold and 4.60-fold increases compared to controls (72.11 ± 6.90-fold for Ccl2; 4.60 ± 0.36-fold for Cxcl2; p < 0.001). This evidence concerns the gene CXCL2 and metabolic dysfunction-associated steatohepatitis.